Cargando…
Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique()
Among the 60 or so various cannabinoids which are present in cannabis sativa indica, terpenophenols are mainly found, including delta-9-trans tetrahydrocannabinol (Δ9-THC) which is the major psychoactive ingredient. Over the last decade, due to the emergence of e-commerce and the continuous investig...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
l'Académie nationale de médecine. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161525/ https://www.ncbi.nlm.nih.gov/pubmed/32300253 http://dx.doi.org/10.1016/j.banm.2020.04.003 |
_version_ | 1783522969540100096 |
---|---|
author | Kintz, P. |
author_facet | Kintz, P. |
author_sort | Kintz, P. |
collection | PubMed |
description | Among the 60 or so various cannabinoids which are present in cannabis sativa indica, terpenophenols are mainly found, including delta-9-trans tetrahydrocannabinol (Δ9-THC) which is the major psychoactive ingredient. Over the last decade, due to the emergence of e-commerce and the continuous investigations by pharmaceutical groups to identify new active molecules, synthetic cannabinoids have been proposed. These compounds, under the generic name “spices” have chemical structures very different from that of Δ9-THC, but share the same CB1 and CB2 receptors. They are mimics of Δ9-THC with much powerful pharmacological effects, including thus more deterrent side-effects, and enhanced windows of detection. All these drugs are controlled. This means that they have to be tested in human biological specimens to document abuse. The aim of this mini-review is to present what has been described in the scientific literature according to the available specimens (blood, urine, saliva, sweat, hair and exhaled breath), focussing on the current advantages and limitations of each test. |
format | Online Article Text |
id | pubmed-7161525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | l'Académie nationale de médecine. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71615252020-04-16 Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique() Kintz, P. Bull Acad Natl Med Revue Générale Among the 60 or so various cannabinoids which are present in cannabis sativa indica, terpenophenols are mainly found, including delta-9-trans tetrahydrocannabinol (Δ9-THC) which is the major psychoactive ingredient. Over the last decade, due to the emergence of e-commerce and the continuous investigations by pharmaceutical groups to identify new active molecules, synthetic cannabinoids have been proposed. These compounds, under the generic name “spices” have chemical structures very different from that of Δ9-THC, but share the same CB1 and CB2 receptors. They are mimics of Δ9-THC with much powerful pharmacological effects, including thus more deterrent side-effects, and enhanced windows of detection. All these drugs are controlled. This means that they have to be tested in human biological specimens to document abuse. The aim of this mini-review is to present what has been described in the scientific literature according to the available specimens (blood, urine, saliva, sweat, hair and exhaled breath), focussing on the current advantages and limitations of each test. l'Académie nationale de médecine. Published by Elsevier Masson SAS. 2020-06 2020-04-16 /pmc/articles/PMC7161525/ /pubmed/32300253 http://dx.doi.org/10.1016/j.banm.2020.04.003 Text en © 2020 l'Académie nationale de médecine. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Revue Générale Kintz, P. Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique() |
title | Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique() |
title_full | Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique() |
title_fullStr | Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique() |
title_full_unstemmed | Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique() |
title_short | Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique() |
title_sort | cannabis et cannabinoïdes de synthèse. à propos de leur détection biologique() |
topic | Revue Générale |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161525/ https://www.ncbi.nlm.nih.gov/pubmed/32300253 http://dx.doi.org/10.1016/j.banm.2020.04.003 |
work_keys_str_mv | AT kintzp cannabisetcannabinoidesdesyntheseaproposdeleurdetectionbiologique |